Does Clearance of Vulvar Lichen Sclerosus after a Corticosteroid Treatment Correspond to a Decrease in Disease-Related Burden? Results from a Cohort Study Using Pictorial Representation of Illness and Self-Measure and the Dermatology Life Quality Index
Conclusions: VLS clearance corresponded to a significant improvement in the QoL of VLS patients, also in comparison with those who achieved a substantial but incomplete decrease of symptom and sign scores, and should become an ideal therapeutic goal.Dermatology (Source: Dermatology)
Source: Dermatology - November 16, 2022 Category: Dermatology Source Type: research
Intranasal Olopatadine: Mometasone in the Treatment of Seasonal Allergic Rhinitis
CONCLUSION: OM significantly improves SAR symptoms and is a viable treatment option in short-term SAR.PMID:36123818 | DOI:10.1177/10600280221124230 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - September 20, 2022 Category: Drugs & Pharmacology Authors: Lauren Lim Melissa Lipari Pramodini Kale-Pradhan Source Type: research
Intranasal Olopatadi: Mometasone in the Treatment of Seasonal Allergic Rhinitis
CONCLUSION: OM significantly improves SAR symptoms and is a viable treatment option in short-term SAR.PMID:36123818 | DOI:10.1177/10600280221124230 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - September 20, 2022 Category: Drugs & Pharmacology Authors: Lauren Lim Melissa Lipari Pramodini Kale-Pradhan Source Type: research
Intranasal Olopatadi: Mometasone in the Treatment of Seasonal Allergic Rhinitis
CONCLUSION: OM significantly improves SAR symptoms and is a viable treatment option in short-term SAR.PMID:36123818 | DOI:10.1177/10600280221124230 (Source: Herpes)
Source: Herpes - September 20, 2022 Category: Infectious Diseases Authors: Lauren Lim Melissa Lipari Pramodini Kale-Pradhan Source Type: research
Intranasal Olopatadi: Mometasone in the Treatment of Seasonal Allergic Rhinitis
CONCLUSION: OM significantly improves SAR symptoms and is a viable treatment option in short-term SAR.PMID:36123818 | DOI:10.1177/10600280221124230 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - September 20, 2022 Category: Drugs & Pharmacology Authors: Lauren Lim Melissa Lipari Pramodini Kale-Pradhan Source Type: research
Intranasal Olopatadine: Mometasone in the Treatment of Seasonal Allergic Rhinitis
CONCLUSION: OM significantly improves SAR symptoms and is a viable treatment option in short-term SAR.PMID:36123818 | DOI:10.1177/10600280221124230 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - September 20, 2022 Category: Drugs & Pharmacology Authors: Lauren Lim Melissa Lipari Pramodini Kale-Pradhan Source Type: research
Intranasal Olopatadine: Mometasone in the Treatment of Seasonal Allergic Rhinitis
CONCLUSION: OM significantly improves SAR symptoms and is a viable treatment option in short-term SAR.PMID:36123818 | DOI:10.1177/10600280221124230 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - September 20, 2022 Category: Drugs & Pharmacology Authors: Lauren Lim Melissa Lipari Pramodini Kale-Pradhan Source Type: research
Review of evidence supporting the use of nasal corticosteroid irrigation for chronic rhinosinusitis
CONCLUSION: Designing more robust clinical trials may help determine if CSI is a valid treatment option. Until more evidence supporting CSI use exists, health care professionals should strongly consider choosing FDA-approved therapies for the treatment of CRS.PMID:36116748 | DOI:10.1016/j.anai.2022.09.008 (Source: Annals of Allergy, Asthma and Immunology)
Source: Annals of Allergy, Asthma and Immunology - September 18, 2022 Category: Allergy & Immunology Authors: Jonathan A Bernstein Andrew A White Joseph K Han David M Lang David Elkayam Fuad M Baroody Source Type: research
In Vitro Regional Deposition of Nasal Sprays in an Idealized Nasal Inlet: Comparison with In Vivo Gamma Scintigraphy
ConclusionsThe AINI was able to mimic regionalin vivo deposition for nasal drug products, permitting differentiation between devices based on regional deposition. (Source: Pharmaceutical Research)
Source: Pharmaceutical Research - September 15, 2022 Category: Drugs & Pharmacology Source Type: research
Mometasone furoate nasal spray in Italian children with seasonal allergic rhinitis: a comprehensive assessment
CONCLUSIONS: The present study documented that a 3-week MFNS treatment was able to significantly dampen type 2 inflammation, improve QoL, and reduce severity of symptoms in Italian children with SAR, and was safe.PMID:36086965 | DOI:10.15586/aei.v50i5.643 (Source: Allergologia et Immunopathologia)
Source: Allergologia et Immunopathologia - September 10, 2022 Category: Allergy & Immunology Authors: Cristiana Indolfi Giulio Dinardo Giuseppina Rosaria Umano Angela Klain Marcella Contieri Alberto Decimo Fabio Decimo Giorgio Ciprandi Michele Miraglia Del Giudice Source Type: research
Mometasone furoate nasal spray in Italian children with seasonal allergic rhinitis: a comprehensive assessment
CONCLUSIONS: The present study documented that a 3-week MFNS treatment was able to significantly dampen type 2 inflammation, improve QoL, and reduce severity of symptoms in Italian children with SAR, and was safe.PMID:36086965 | DOI:10.15586/aei.v50i5.643 (Source: Allergologia et Immunopathologia)
Source: Allergologia et Immunopathologia - September 10, 2022 Category: Allergy & Immunology Authors: Cristiana Indolfi Giulio Dinardo Giuseppina Rosaria Umano Angela Klain Marcella Contieri Alberto Decimo Fabio Decimo Giorgio Ciprandi Michele Miraglia Del Giudice Source Type: research
